cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene

Carcinogenesis

Volumn 23, Issue 10, 2002, Pages 1561-1568

  Shan, Liang ^a   He, Mei ^a   Yu, Minshu ^a   Qiu, Cunping ^a   Lee, Norman H ^b   Liu, Edison T ^a   Snyderwine, Elizabeth G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Institute of Genomics Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; CELL CYCLE PROTEIN; COMPLEMENTARY DNA; CYCLIN D1; PLATELET DERIVED GROWTH FACTOR A; RETINOL BINDING PROTEIN; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; COOKING; DNA DETERMINATION; DNA MICROARRAY; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LACTATION; MALIGNANT TRANSFORMATION; MAMMARY GLAND; MEAT; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; RAT STRAIN; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

EID: 0036798690     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.10.1561     Document Type: Article

References (54)

1. Beckmann, M.W., Niederacher, D., Schnürch, H.-G., Gusterson, B.A. and Bender, H.G. (1997) Multistep carcinogenesis of breast cancer and tumor heterogeneity. J. Mol. Med., 75, 429-439.
2. Ingvarsson, S. (1999) Molecular genetics of breast cancer progression. Semin. Cancer Biol., 9, 277-288.
3. Perou, C.M., Sørlie, T., Eisen, M.B. et al. (2000) Molecular portraits of human breast tumors. Nature, 406, 747-752.
4. Kerangueven, F., Noguchi, T., Coulier, F. et al. (1997) Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57, 5469-5474.
5. Dangond, F. (2000) Chips around the world: proceedings from the Nature Genetics microarray meeting. Physiol. Genomics, 2, 53-58.
6. Liotta, L. and Petricoin, E. (2000) Molecular profiling of human cancer. Nature Rev., 1, 48-56.
7. Perou, C.M., Jeffrey, S.S., van de Rijn, M. et al. (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancer. Proc. Natl Acad. Sci. USA, 96, 9212-9217.
8. Sørlie, T., Perou, C.M., Tibshirani, R. et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA, 98, 10869-10874.
9. Russo, J., Gusterson, B.A., Rogers, A.E., Russo, I.H., Wellings, S.R. and van Zwieten, M.J. (1990) Biology of disease. Comparative study of human and rat mammary tumorigenesis. Lab. Invest. 62, 244-278.
10. Huggins, C., Grand, L.C. and Brillantes, F.P. (1961) Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature 189, 204-207.
11. Snyderwine, E.G. (1999) Dietary heterocyclic amines and breast cancer. Women Cancer, 1, 21-29.
12. Sinha, R., Gustafson, D.R., Kulldorff, M., Wen, W., Cerhan, J.R. and Zheng, W. (2000) 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature cooked meat and breast cancer risk. J. Natl Cancer Inst., 92, 1352-1353.
13. Ghoshal, A., Preisegger, K.H., Takayama, S., Thorgeirsson, S.S. and Snyderwine, E.G. (1994) Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat. Carcinogenesis, 15, 2429-2433.
14. Snyderwine, E.G., Thorgeirsson, U.P., Venugopal, M. and Roberts-Thomson, S.J. (1998) Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Sprague-Dawley rats on high- and low-fat diets. Nutr. Cancer, 31, 160-167.
15. Ushijima, T., Kakiuchi, H., Makino, H. et al. (1994) Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mol. Carcinogen., 10, 38-44.
16. Davis, C.D. and Snyderwine, E.G. (1995) Analysis of EGFR, TGF-a, neu and c-myc in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary tumors using RT-PCR. Carcinogenesis, 16, 3087-3092.
17. Toyota, M., Ushijima, T., Weisburger, J.H., Hosoya, Y., Canzian, F., Rivenson, A., Imai, K., Sugimura, T. and Nagao, M. (1996) Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mol. Carcinogen., 15, 176-182.
18. Roberts-Thomson, S.J. and Snyderwine, E.G. (1997) Effect of dietary fat on codon 12 and 13 Ha-ras gene mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine- induced rat mammary gland tumors. Mol. Carcinogen., 20, 348-354.
19. Roberts-Thomson, S.J. and Snyderwine, E.G. (2000) Characterization of peroxisome proliferator-activated receptor alpha in normal rat mammary gland and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary gland tumors from rats fed high and low fat diets. Toxicol. Lett., 118, 79-86.
20. Watanabe, N., Okochi, E., Hirayama, Y et al. (2001) Single nucleotide instability without microsatellite instability in rat mammary carcinomas. Cancer Res., 61, 2632-2640.
21. Hokaiwado, N., Asamoto, M., Cho, Y.-M., Imaida, K. and Shirai. T. (2001) Frequent c-Ha-ras gene mutations in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Lett., 163, 187-190.
22. Yu, M., Ryu, D.-Y. and Snyderwine, E.G. (2000) Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mol. Carcinogen., 27, 76-83.
23. Christian, A., Snyderwine, E.G. and Tucker, J.D. (2002) Comparative genomic hybridization analysis of PhIP-induced mammary carcinomas in rats reveals a cytogenetic signature. Mutat. Res. (in press)
24. Sgambato, A., Han, E.K.-H., Zhang, Y., Moon, R.C., Santella, R.M. and Weinstein, I.B. (1995) Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis, 16, 2193-2198.
25. Lu, J., Pei, H., Kaeck, M. and Thompson, H.J. (1997) Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol. Carcinogen., 20, 204-215.
26. Kip1 in chemically induced rat mammary carcinogenesis. Jpn. J. Cancer Res., 91, 1222-1232.
27. Trombino, A.F, Near R.I., Matulka, R.A. et al. (2000) Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res. Treat., 63: 117-131.
28. Kim, D.W., Sovak, M.A., Zanieski, G. et al. (2000) Activation of NF-kB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21, 871-879.
29. Huang, R.Y. and Ip., M.M. (2001) Differential expression of integrin mRNAs and proteins during normal rat mammary gland development and in carcinogenesis. Cell Tissue Res., 303, 69-80.
30. Wang, Y., Hu, L., Yao, R., Wang, M., Crist, K.A., Grubbs, C.J., Johanning, G.L., Lubert, R.A. and You, M. (2001) Altered gene expression profile in chemically induced mammary adenocarcinomas and its modulation by an aromatase inhibitor. Oncogene, 20, 7710-7721.
31. Russo, J. and Russo,I.H. (2000) Atlas and histologic classification of tumors of the rat mammary gland. J. Mammary Gland Biol. Neoplasia, 5, 187-200.
32. Guo, Q.M., Malek, R.L., Kim, S. et al. (2000) Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res., 60, 5922-5928.
33. Topper, Y.J. and Freeman, C.S. (1980) Multiple hormone interactions in the developmental biology of the mammary gland. Physiol. Rev., 60, 1049-1106.
34. Henninghausen,L. and Robinson, G.W. (1998) Think globally, act locally: the making of a mouse mammary gland. Genes Dev., 12, 449-455.
35. Barnes, D.M. and Gillett, C.E. (1998) Cyclin D1 in breast cancer. Breast Cancer Res. Treat., 52, 1-15.
36. De Jong, J.S., Van Diest, P.J., Valk, P.V.D. and Baak, J.P.A. (1998) Expression of growth factors, growth inhibiting factors and their receptors in invasive breast cancer. I: an inventory in search of autocrine and paracrine loops. J. Pathol., 184, 44-52.
37. De Jong, J.S., Van Diest, P.J., Valk,P.V.D. and Baak, J.P.A. (1998) Expression of growth factors, growth inhibiting factors and their receptors in invasive breast cancer. II: correlations with proliferation and angiogenesis. J. Pathol., 184, 53-57.
38. Curmi, P.A., Noguès, C., Lachkar, S., Carelle, N., Gonthier, M.-P., Sobel, A., Lidereau, R. and Bièche, I. (2000) Overexpression of stathmin in breast carcinomas points out to highly proliferative tumors. Br. J. Cancer, 82, 142-150.
39. Chen, L., O'Bryan, J.P., Smith, H.S. and Edison, Liu. (1990) Overexpression of matrix Gla protein mRNA in malignant human breast cells: isolation by differential cDNA hybridization. Oncogene, 5, 1391-1395.
40. Hough, C.D., Cho, K.R., Zonderman, A.B., Schwartz, D.R. and Morin, P.J. (2001) Coordinately up-regulated genes in ovarian cancer. Cancer Res., 61, 3869-3876.
41. Wang, S., Nath, N., Adlam, M. and Chellappan, S. (1999) Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene, 18, 3501-3510.
42. Jupe, E.R., Badgett, A.A., Neas, B.R., Craft, M.A., Mitchell, D.S., Resta, R., Mulvihill, J.J., Aston, C.E. and Thompson, L.F. (2001) Single nucleotide polymorphism in prohibitin 3′ untranslated region and breast-cancer susceptibility. Lancet, 357, 1588-1589.
43. Hardwick, M., Fertikh, K., Culty, M., Li, H., Vidic, G. and Papadopoulos, V. (1999) Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res., 59, 831-842.
44. Watson, C.J. and Miller, W.R. (1995) Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer, 71, 840-844.
45. Yu, M., Jones, M.L., Gong, M., Sinha, R., Schut, H.A.J. and Snyderwine, E.G. (2002) Mutagenicity of 2-amino-1-methyl-6-phenylimidaz[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high and low fat diets. Carcinogenesis 23, 877-884.
46. Manjanatha, M.G., Shelton, S.D., Culp, S.J., Blankenship, L.R. and Casciano, D.A. (2000) DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue rats treated with 7, 12-dimethylbenz[a]anthracene. Carcinogenesis, 21, 265-273.
47. Vonderhaar, B.K. (1999) Prolactin involvement in breast cancer. Endocr. Relat. Cancer, 6, 389-404.
48. Bromberg, J. (2000) Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Res. 2, 86-90.
49. Liu, X, Robinson,G.W. and Hennighausen, L. (1996) Activation of STAT5a and STAT5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol. Endocrinol., 10, 1496-1501.
50. Humphreys, R.C. and Henninghausen, L. (1999) Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Diff., 10, 685-694.
51. Liu, X., Robinson, G.W., Wagner K.-U., Garrett, L., Wynshaw-Boris, A. and Henninghausen, L. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev., 11, 179-186.
52. Matsumura, I., Kitamura, T., Wakao, H., Tanaka, H., Hashimoto, K., Albanese, C., Downward, J., Pestell, R.G. and Kanakura, Y. (1999) Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J., 18, 1367-1377.
53. L induction. Cell, 98, 181-191.
54. Bowman, T., Garcia, R., Turkson, J. and Jove, R. (2000) STATs in oncogenesis. Oncogene, 19, 2474-2488.